Patent · US Active

Antibodies to PfGARP kill Plasmodium falciparum malaria parasites and protect against infection and severe disease

US12037386B2 · kind B2 · utility

0Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2023
Grant dateJul 16, 2024
Priority date
Expiry dateMay 10, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods, compositions and kits for preventing and treating malaria. Also included herein are kits for preventing and treating malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.